Remission of major depression and obsessive-compulsive disorder after a single unilateral ECT [1]

Journal of ECT

Volumn 19, Issue 1, 2003, Pages 50-51

  Thomas, Stephanie G ^a   Kellner, Charles H ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE; FLUVOXAMINE; HALOPERIDOL; LORAZEPAM; PAROXETINE; RISPERIDONE;

ADULT; ANXIETY; AUDITORY HALLUCINATION; CASE REPORT; CLINICAL FEATURE; CRYING; ELECTROCONVULSIVE THERAPY; FAMILY HISTORY; HUMAN; LETTER; MAJOR DEPRESSION; MALE; OBSESSIVE COMPULSIVE DISORDER; PARANOIA; SLEEP DISORDER; SUICIDAL BEHAVIOR; SYMPTOM; TREATMENT OUTCOME;

ADULT; DEPRESSIVE DISORDER; ELECTROCONVULSIVE THERAPY; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; TREATMENT OUTCOME;

EID: 0037218042     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124509-200303000-00011     Document Type: Letter

References (4)

1. Segman RH, Shapira B, Gorfine M, et al. Onset and time course of antidepressant action: psychopharmacological implications of a controlled trial of ECT. Psychopharmacology 1995;119:440-8.
2. Chiodo LA, Antelman SM. Electroconvulsive shock: progressive dopamine autoreceptor subsensitivity independent of repeated treatment. Science 1980;210:799-801.
3. Sermet E, Gregoire MC, Galy G, et al. Paradoxical metabolic response of the human brain to a single electroconvulsive shock. Neurosci Lett 1998;254:41-4.
4. Hayakawa H, Okamoto Y, Shimizu M, et al. Single or repeated treatment with electroconvulsive shock increases number of serotonin uptake binding sites in the frontal cortex. Neuropsychobiology 1995;31: 1-5.